Purinergic Signalling (2014) 10:477–486
DOI 10.1007/s11302-014-9410-y
ORIGINAL ARTICLE
Role of adenosine A2B receptor signaling in contribution
of cardiac mesenchymal stem-like cells to myocardial scar
formation
Sergey Ryzhov & Bong Hwan Sung & Qinkun Zhang &
Alissa Weaver & Richard J. Gumina & Italo Biaggioni &
Igor Feoktistov
Received: 19 September 2013 / Accepted: 18 February 2014 / Published online: 1 March 2014
# Springer Science+Business Media Dordrecht 2014
Abstract Adenosine levels increase in ischemic hearts and
contribute to the modulation of that pathological environment.
We previously showed that A2B adenosine receptors on mouse
cardiac Sca1+CD31− mesenchymal stromal cells upregulate
secretion of paracrine factors that may contribute to the improvement in cardiac recovery seen when these cells are
transplanted in infarcted hearts. In this study, we tested the
hypothesis that A2B receptor signaling regulates the transition
of Sca1+CD31− cells, which occurs after myocardial injury,
into a myofibroblast phenotype that promotes myocardial
repair and remodeling. In vitro, TGFβ1 induced the expression of the myofibroblast marker α-smooth muscle actin
(αSMA) and increased collagen I generation in Sca1+CD31−
cells. Stimulation of A2B receptors attenuated TGFβ1induced collagen I secretion but had no effect on αSMA
expression. In vivo, myocardial infarction resulted in a rapid
increase in the numbers of αSMA-positive cardiac stromal
cells by day 5 followed by a gradual decline. Genetic deletion
of A2B receptors had no effect on the initial accumulation of
αSMA-expressing stromal cells but hastened their subsequent
decline; the numbers of αSMA-positive cells including
Sca1+CD31− cells remained significantly higher in wild type
Electronic supplementary material The online version of this article
(doi:10.1007/s11302-014-9410-y) contains supplementary material,
which is available to authorized users.
S. Ryzhov : B. H. Sung : Q. Zhang : A. Weaver : R. J. Gumina :
I. Biaggioni
Divisions of Cardiovascular Medicine (SR, QZ, RJG, IF) and
Clinical Pharmacology (IB), Departments of Medicine (SR, QZ,
RJG, IB, IF), Cancer Biology (BHS, AW) and Pharmacology (RJG,
IB, IF), Vanderbilt University Medical School, Nashville, TN, USA
I. Feoktistov (*)
Vanderbilt University, 360 PRB, 2220 Pierce Ave, Nashville,
TN 37232-6300, USA
e-mail: igor.feoktistov@vanderbilt.edu
compared with A2B knockout hearts. Thus, our study revealed
a significant contribution of cardiac Sca1+CD31− cells to the
accumulation of αSMA-expressing cells after infarction and
implicated A2B receptor signaling in regulation of myocardial
repair and remodeling by delaying deactivation of these cells.
It is plausible that this phenomenon may contribute to the
beneficial effects of transplantation of these cells to the injured
heart.
Keywords Adenosine . Receptor . Adenosine A2B .
Mesenchymal stromal cells . Myofibroblasts . Myocardial
infarction . Alpha-smooth muscle actin
Introduction
Cardiac multipotent mesenchymal stem-like cells have been
proposed as candidates for cell-based transplantation therapy
to enhance tissue repair and functional recovery after myocardial infarction (MI) [1, 2]. In the mouse’s heart, these cells are
represented by a population of stromal cells characterized by
cell-surface expression of stem cell antigen (Sca)-1 and absence of the endothelial cell marker CD31 [3–11]. Several
groups, including our laboratory, have demonstrated that the
delivery of cardiac Sca1+CD31− cells to the injured heart
attenuates the decline in cardiac function and the adverse
remodeling in animal models of MI [6, 9, 11–13].
MI is known to increase interstitial adenosine concentrations to levels sufficient to engage all adenosine receptors,
including the low-affinity A2B subtype [14–16]. The A2B
receptor is expressed on mesenchymal stem/progenitor cells
isolated from various tissues [10, 17–22] and represents the
functionally predominant adenosine receptor subtype in cardiac Sca1+ mesenchymal stem-like cells [10]. Importantly, we
have recently demonstrated that A2B adenosine receptor
478
signaling, linked to upregulation of paracrine factors in cardiac Sca1+CD31− cells, is essential for the improvement of
cardiac recovery resulting from transplantation of these cells
to the injured heart [11]. On the other hand, we found no
evidence that A2B receptors promote cardiomyogenic differentiation of cardiac mesenchymal stem-like cells [10].
Recent evidence suggests that cardiac mesenchymal stemlike cells respond to stimulation with TGFβ in vitro, or to
myocardial injury in vivo, by displaying myofibroblast characteristics that include an increased synthesis of extracellular
matrix (ECM) components and the expression of the contractile protein α-smooth muscle actin (αSMA) [23–25]. The
rapid accumulation and activity of cardiac myofibroblasts
early after myocardial injury is thought to be critical for proper
scar formation [26]. Because the A2B adenosine receptor
signaling is important for overall improvement of cardiac
recovery seen after transplantation of cardiac Sca1+CD31−
cells to the infarcted heart [11], we hypothesized that it may
also play a role in this novel aspect of mesenchymal stem-like
cell function. In this study, we examined TGFβ-induced collagen I generation and the expression of αSMA by cardiac
Sca1+CD31− cells in vitro and evaluated the effect of stimulation of A2B adenosine receptors on these events. We also
examined temporal changes in αSMA and collagen I expression in resident cardiac Sca1+CD31− cells in vivo after
performing experimental MI in A2B receptor knockout (KO)
and wild-type (WT) mice.
Materials and methods
Reagents Dulbecco's Modified Eagle Medium (DMEM)
(high glucose) was purchased from Invitrogen Corporation
(Carlsbad, CA). Porcine transforming growth factor β1
(TGFβ1) and mouse interferon γ (IFNγ) were purchased
from R&D Systems (Minneapolis, MN). 5'-Nethylcarboxamidoadenosine (NECA), fetal bovine serum
(FBS), Antibiotic-Antimycotic solution, and dimethyl sulfoxide (DMSO) were purchased from Sigma (St. Louis, MO).
When used as a solvent, final DMSO concentrations in all
assays did not exceed 0.1 %, and the same DMSO concentrations were used in vehicle controls.
Animals All studies were conducted in accordance with the
Guide for the Care and Use of Laboratory Animals as adopted
and promulgated by the US National Institutes of Health.
Animal studies were reviewed and approved by the institutional animal care and use committee of Vanderbilt University.
A2BKO mice were obtained from Deltagen (San Mateo, CA),
and WT C57BL/6 mice were purchased from Harlan World
Headquarters (Indianapolis, IN). All of the A2BKO mice used
in these studies were backcrossed to the C57BL/6 genetic
background for more than 10 generations.
Purinergic Signalling (2014) 10:477–486
Myocardial infarction Surgical procedures to produce myocardial infarction in mice by permanent ligation of the left
coronary artery were performed in the Cardiovascular
Pathophysiology and Complications Core of the Vanderbilt
University Mouse Metabolic Phenotyping Center as previously described [11].
Mouse cardiac Sca1+CD31− stromal cells Conditionally immortalized cardiac Sca1+CD31− stromal cell line was generated as described previously [10] from H-2Kb-tsA58 transgenic mice carrying a thermolabile T antigen. Cells were
propagated on 0.1 % gelatin-coated tissue culture dishes in
DMEM (high glucose) medium supplemented with 10 %
FBS, 1X Antibiotic-Antimycotic solution, 2 mM glutamine,
and 10 ng/ml of IFNγ under humidified atmosphere of air/
CO2 (19:1) at a low temperature (33 °C). Six days before
experiments, cells were replated and cultured in the absence of
IFNγ at a higher temperature (37 °C) to allow them to revert to
their primary phenotype as described previously [10].
Western blot analysis of collagen type I To investigate the
effect of TGFβ and NECA on the expression, secretion, and
deposition of collagen I, Sca1+CD31− cells were seeded on
tissue culture-treated plates and cultured in DMEM medium
supplemented with 10 % FBS, 1X Antibiotic-Antimycotic
solution, and 2 mM glutamine for 24 h. Next day, culture
media were changed with serum-free media supplemented
with 1 ng/ml TGFβ1 and/or 30 μM NECA. After 48 h,
conditioned media were collected, and total cell lysates were
prepared using SDS lysis buffer. To prepare cell-free ECM,
cells were lysed using 25 mM Tris-HCl (pH7.4)/150 mM
NaCl/0.5 % Triton X-100/20 mM NH4OH. Cell debris was
washed using deionized water followed by PBS. Cell-free
ECM remaining on tissue culture plates was collected using
SDS sample buffer with β-mercaptoethanol. Equal volume of
conditioned media and cell-free ECM and equal amount of
total cell lysates from each treatment were resolved on 8 %
SDS-PAGE. After blotting, the membrane was probed with
antibodies raised against collagen type I (600-401-103;
Rockland, Inc., Rockland, PA) or β-actin (Sigma) as a primary antibody and Streptavidin Poly-HRP Conjugate (Thermo
Scientific, Inc., Waltham, MA) and HRP-conjugated antirabbit IgG (Santa Cruz Biotechnology, Inc., Dallas, TX) as a
secondary antibody. Blots were then developed using
SuperSignal West Femto Chemiluminescent Substrate
(Thermo Scientific) and quantified by densitometry using
ImageJ 1.45s software (National Institutes of Health,
Bethesda, MD).
Flow cytometry All cells were analyzed either freshly isolated
or after treatment with Accutase-Enzyme Cell Detachment
Medium (eBioscience, San Diego, CA). Isolation of cardiac
stromal cell populations was performed as previously
Purinergic Signalling (2014) 10:477–486
described [11]. In brief, both right and left ventricles were
dissected from hearts, minced, and incubated with 10 ml of
Digestion Solution (10 mg/ml collagenase II, 2.5 U/ml dispase
II, 1 μg/ml DNase I, and 2.5 mM CaCl2) for 20 min at 37 °C.
Filtered myocyte-free single-cell suspensions (∼5x105) were
washed and resuspended in 100 μl of PBS containing 0.5 %
BSA and 2 mM EDTA (PBS/BSA/EDTA) and 2 μl of murine
Fc block reagent (clone 2.4G, BD Biosciences, San Jose, CA).
The cells were then incubated with relevant antibodies for
20 min at 4 °C, washed once with 10 volumes of cold PBS/
BSA/EDTA, and resuspended in a final volume of 500 μl.
Cell-surface antigens were stained with PE-conjugated antimouse CD31 or Sca-1 (eBioscience), PeCy7-conjugated Sca1 or CD45, anti-CD105-APC or CD31-APC (Biolegend, San
Diego, CA), and anti-CD45-V450 (BD Biosciences) antibodies. After treatment with Cytofix/Cytoperm kit (BD
Biosciences), the permeabilized cells were stained for
αSMA and collagen type I using monoclonal FITCconjugated anti-αSMA (Sigma) and biotin-conjugated anticollagen type I (600-401-103; Rockland, Inc., Rockland, PA)
antibodies. Streptovidin-PeCy7 (eBioscience) or StreptavidinPacific Blue (Life Technologies) conjugates were used to
detect biotin-conjugated antibodies. Mouse IgG2a-FITC(Sigma) and biotin-conjugated rabbit whole IgG (Jackson
ImmunoResearch, Inc., West Grove, PA) were used as an
isotype control. Viable and non-viable cells were distinguished using LIVE/DEAD® Fixable Blue Stain kit (Life
Technologies, Carlsbad, CA). Data acquisition was performed
using LSRII flow cytometer (BD, Franklin Lakes, NJ), and the
data were analyzed with WinList 5.0 software. Antigen negativity was defined as having the same fluorescent intensity as
the isotype control.
Statistical analysis Data were analyzed using the GraphPad
Prism 4.0 software (GraphPad Software Inc., San Diego, CA)
and presented as mean±SEM. Comparisons between several
treatment groups were performed using one-way ANOVA
followed by Bonferroni post-hoc tests. Comparisons between
two groups were performed using two-tailed unpaired t tests.
A p value <0.05 was considered significant.
Results
Analysis of collagen I generation and the expression of αSMA
by cardiac Sca1+CD31− cells in vitro We have previously
shown that mouse cardiac Sca1+CD31− cells, used in the
current study, express predominantly the A2B subtype of
adenosine receptors. Although low levels of A2A receptor
transcripts were also detected, no evidence of their functional
activity was found; only the non-selective adenosine agonist
NECA, but not the selective agonist CGS 21680 stimulated
479
cAMP accumulation in these cells [10]. To determine whether
adenosine signaling in cardiac mesenchymal stem-like cells
plays a role in the production of the common ECM component
collagen I, we cultured mouse cardiac Sca1+CD31− cells on
uncoated plastic plates in the absence or presence of the stable
adenosine analog NECA (30 μM) and in the absence or
presence of the pro-fibrotic factor TGFβ1 (1 ng/ml) for
48 h. Figure 1a shows representative Western blots of conditioned media, cell-free ECM, and cell lysates analyzed with an
antibody, which specifically recognizes the pro-α1 chain, the
mature α1 chain, and the heterotrimer of type I collagen [27].
The expression of the 140 kDa pro-collagen α1(I) chains was
clearly seen in cell lysates, whereas secretion of collagen I into
media and its deposition on the plate surface were also evident
by immunostaining of higher molecular weight bands
representing heteromeric mature forms of type I collagen.
Additional lower molecular weight bands seen only in conditioned media but not in extracellular matrix or cell lysates may
represent accumulation of products of collagen I degradation.
Stimulation of Sca1+CD31− cells with TGFβ1 resulted in a
several-fold increase in intracellular pro-collagen levels, accumulation of extracellular collagen I in conditioned media,
and its deposition on the plate surface. Stimulation of adenosine receptors on Sca1+CD31− cells with NECA, however,
had much smaller effects on collagen I levels compared to the
effects of TGFβ1. In the absence of TGFβ1, NECA had a
tendency to increase intracellular pro-collagen levels and collagen I secretion by 1.4–1.6 fold, though these changes did not
reach statistical significance (Fig. 1b). In contrast, stimulation
of adenosine receptors in Sca1+CD31− cells attenuated
TGFβ-induced increase in collagen I levels in both conditioned media and ECM deposits by approximately 25 %,
though only the changes in collagen I levels in conditioned
media reached statistical significance. No difference in intracellular pro-collagen I levels was seen between cells stimulated with TGFβ1 in the absence and presence of NECA
(Fig. 1a, b). These results suggest that stimulation of adenosine receptors with NECA in TGFβ-activated Sca1+CD31−
cells primarily inhibits collagen I release into conditioned
medium. Conversely, in the absence of TGFβ1, NECA had
a tendency to increase both intracellular pro-collagen I levels
and collagen I release from non-activated Sca1+CD31− cells
in vitro. The effects of NECA on collagen I secretion were
A2B receptor-specific because they were not observed in
A2BKO cells used as an off-target control (Fig. 1c, d).
In a separate set of experiments, we cultured mouse cardiac
Sca1+CD31− cells in the absence or presence of 30 μM NECA
and in the absence or presence of 1 ng/ml TGFβ1 for 24 h and
analyzed the expression of αSMA by fluorescence-activated
cytometry sorting (FACS). Representative cytofluorographic
dot plots of negative αSMA staining with an isotype-matched
non-specific antibody are presented in Online Resource Fig. 1.
In our cell culture conditions, even in the absence of TGFβ1
480
Purinergic Signalling (2014) 10:477–486
Fig. 1 Stimulation of adenosine signaling with NECA attenuates TGFβinduced secretion of collagen type I from cardiac Sca1+CD31− cells
in vitro. Representative Western blots (a) and densitometric analysis (b)
of collagen type I (α1 chain) in conditioned media, cell-free extracellular
matrix (ECM), and total cell lysates obtained after incubation of cardiac
Sca1+CD31− cells in the absence (C, N) or presence (T, TN) of 1 ng/ml
TGFβ1 and in the absence (C, T) or presence (N, TN) of 10 μM NECA
for 48 h. Molecular weight markers are shown on the far right, and βactin was used as a loading control for analysis of cell lysates. Values are
presented as means±SEM of three experiments. Asterisks indicate statistical difference (***p<0.001) compared to values obtained in the absence
of TGFβ1, dagger indicates statistical difference (†p<0.05), and ns
indicates non-significant differences compared to corresponding values
obtained in the absence of NECA by one-way ANOVA with Bonferroni
post-hoc tests. Western blots (c) and densitometric analysis (d) of collagen type I (Coll I) secretion into conditioned media from A2B knockout
(A2BKO) Sca1+CD31− cells are shown as a negative control for A2B
receptor signaling
(Fig. 2c). In contrast, stimulation of adenosine receptors with
NECA had no significant effect on the expression of αSMA
both in the presence or absence of TGFβ1.
and NECA, 14.5±1 % of total cell population expressed
αSMA (Fig. 2). Stimulation of cells with TGFβ1 produced
a three-fold increase in the proportion of αSMA-positive cells
(Fig. 2b) and mean fluorescence intensity of αSMA staining
Analysis of the expression of αSMA and collagen I by cardiac
Sca1+CD31− cells in a mouse model of MI TGFβ1 is only
one of a multitude of factors that can promote stromal cell
differentiation toward myofibroblast phenotype after myocardial injury. Obviously, stimulation of Sca1+CD31− cells with
Fig. 2 Stimulation of adenosine signaling with NECA has no effect on
TGFβ-induced expression of αSMA in cardiac Sca1+CD31− cells
in vitro. Representative cytofluorographic dot plots (a) of intracellular
αSMA staining in cardiac Sca1+CD31− cells cultured in the absence
(control) or presence (TGFβ) of 1 ng/ml TGFβ1 and in the absence
(−NECA) or presence (+NECA) of 10 μM NECA for 24 h. The percentages of αSMA-positive cells (b) and their mean fluorescence intensity
(ΔMFI) (c) are presented as means±SEM of three experiments. Asterisks
indicate statistical differences (**p<0.01, ***p<0.001) and ns indicates
non-significant differences analyzed by one-way ANOVA with
Bonferroni post-hoc tests
Purinergic Signalling (2014) 10:477–486
TGFβ1 in vitro cannot reproduce the complexity of their
activation induced by MI in the heart. To gain insight into
MI-induced dynamics of αSMA expression in a general stromal cell population and the potential role of A2B receptor
signaling, we created experimental MI in A2BKO and WT
mice by permanent ligation of the left coronary artery.
Cardiomyocyte-free cell suspensions were prepared from ventricles collected at different time points after MI induction.
Gating strategy for the FACS analysis of αSMA expression in
cardiac non-hematopoietic cells is presented in Online
Resource Fig. 2. We found that only a small proportion of
cells, representing approximately 2 % of non-hematopoietic
cell population, expressed αSMA in non-infarcted hearts (d0,
Fig. 3a). It is likely that this minor cell fraction consisted
largely of vascular smooth muscle cells which express
αSMA under normal conditions. MI induced a rapid rise in
the proportion of αSMA-expressing cells in the population of
stromal (CD31−) but not endothelial (CD31+) cells (Fig. 3a).
An increase in numbers of αSMA-positive stromal cells,
which peaked by post-MI day 5, was followed by gradual
decline in their numbers over the next 16 days to nearly preinfarct levels (Fig. 3b). Whereas no difference in numbers of
αSMA-expressing cells was seen between A2BKO and WT
hearts during their rise on post-MI days 3 and 5, the numbers
of αSMA-expressing cells remained significantly higher in
WT compared with A2BKO hearts during their decline
(Fig. 3b). To determine if an increase in αSMA-expressing
cell death rate in A2BKO hearts could contribute to this phenomenon, we analyzed changes in cell viability produced by
MI on days 3, 7, and 14 in myocyte-free cell suspensions
obtained from A2BKO and WT ventricles. As seen in Fig. 4a,
MI produced an initial rise in proportion of non-viable cells by
13 % on day 3, which was reversed by days 7 and 14
comprising only 1.7–2.8 % of total cell populations.
However, we found no significant differences between WT
and A2BKO hearts in MI-induced total cell death (Fig. 4a) or
proportion of αSMA-expressing stromal cells within nonviable cell populations (Fig. 4b). Proportion of non-viable
αSMA-expressing stromal cells in A2BKO hearts tended to
be even lower compared to WT hearts on post-MI days 7 and
14 suggesting that accelerated decline in αSMA-expressing
stromal cell populations in A2BKO versus WT hearts seen in
Fig. 3 cannot be explained by their higher death rate.
Next, we selected post-MI days 7 and 14 to determine if
there was also a difference in numbers of Sca1+CD31− cells
between A 2 B KO and WT hearts. Representative
cytofluorographic dot plots of negative Sca1+ staining with
an isotype-matched non-specific antibody are presented in
Online Resource Fig. 3. Normal non-infarcted A2BKO and
WT hearts contained similar populations of Sca1+CD31−
cells (d0, Fig. 5). In agreement with previous reports [6,
10], MI induced a significant increase in Sca1+CD31−
cell numbers. We found that proportion of Sca1+CD31−
481
Fig. 3 A2B receptor signaling controls deactivation of αSMA expression
in total stromal cell population of infarcted ventricles. Representative
cytofluorographic outlier contour plots of CD31 and αSMA expression
(a) and the numbers of CD31− stromal cells expressing αSMA per
milligram of tissue (b) in CD45− myocyte-free cell populations obtained
from ventricles of WT and A2BKO hearts before (d0) and on different
days (d3–d21) after MI. Values are means±SEM of 4–6 animals in each
group. Asterisks indicate statistical differences (*p<0.05, **p<0.01)
between WT and A2BKO values analyzed at each time point by unpaired
two-tailed t test
482
Purinergic Signalling (2014) 10:477–486
(Fig. 5c), whereas the numbers of αSMA-negative
Sca1+CD31− cells were not significantly altered by MI
(Fig. 6d, e). Thus, our data suggest that the increase in total
Sca1+CD31− cell population induced by MI occurs primarily
due to generation of αSMA-expressing Sca1+CD31− cells.
Although some of the newly generated αSMA-expressing
Sca1+CD31− cells also expressed collagen I (Fig. 6b), a substantial number of αSMA-expressing Sca1+CD31− remained
collagen-negative (Fig. 6c). Again, the numbers of αSMAexpressing Sca1+CD31− both negative and positive for the
expression of collagen I were significantly higher in WT
compared with A2BKO hearts on post-MI days 7 and 14
(Fig 6b, c), whereas ablation of A2B receptor signaling in
A2BKO hearts had no significant effect on the numbers of
αSMA-negative Sca1+CD31− cells (Fig 6d, e). Taken together, our results indicate that A2B adenosine receptor signaling
delays the reversal of Sca1+CD31− cells from their differentiated myofibroblast-like state back to their resting state.
Discussion
Fig. 4 Comparative analysis of MI-induced changes in non-viable cell
populations from WT and A2BKO ventricles. MI-induced changes in total
cell viability (a) determined as difference (Δ) between percentages of
non-viable cells in total myocyte-free cell populations obtained from
ventricles of WT and A2BKO mice on days 3, 7, and 14 post-MI and
percentages of non-viable cells in total myocyte-free cell populations
obtained from non-infarcted ventricles of corresponding control mice.
Percentages of α-SMA-expressing stromal (CD31−) cells (b) in nonviable myocyte-free cell populations obtained from ventricles of WT
and A2BKO mice on days 3, 7, and 14 post-MI. Values are means±
SEM of 4–6 animals in each group
cells in non-hematopoietic cell population (Fig 5b) and their
numbers (Fig 5c) were significantly higher in WT compared
with A2BKO hearts on post-MI days 7 and 14. Finally, we
analyzed the expression of αSMA and collagen 1 in the
populations of Sca1+CD31− cells obtained from A2BKO and
WT hearts. Representative cytofluorographic dot plots of
negative αSMA and collagen I staining with control isotypematched antibodies are presented in Online Resource Fig. 4.
Before MI, the majority of the cardiac Sca1+CD31− cell
population (over 75 %) were double-negative for αSMA
and collagen I expression; an even greater proportion of
Sca1+CD31− cells (>90 %) were negative for the expression
of αSMA (d0, Fig. 6). MI induced a significant increase in
proportion of Sca1+CD31− cells expressing αSMA on postMI days 7 and 14. Remarkably, the MI-induced changes in
αSMA-expressing Sca1+CD31− cell numbers (Fig. 6b, c)
followed dynamics seen in total Sca1+CD31− cell population
Cardiac mesenchymal stem-like cells received much attention
lately due to their potential to transdifferentiate into various
cell lineages. Under appropriate cell culture conditions, these
cells can undergo cardiomyogenic, osteogenic, adipogenic,
and chondrogenic differentiation [4, 10, 12, 23]. We have
previously reported that stimulation of A2B receptors on cardiac Sca1+CD31− cells had no effect on their in vitro differentiation toward cardiomyogenic, osteogenic, or adipogenic
lineages [10]. In this study, we also found no significant effect
of stimulation of A2B receptors on the expression of the
myofibroblast marker αSMA in cardiac Sca1+CD31− cultured
in the presence of TGFβ. The steady-state levels of intracellular pro-collagen I were also unaffected, but TGFβ-induced
secretion of collagen I into media and its deposition on the
plate surface were attenuated by stimulation of adenosine
receptors. Similar adenosine A2B receptor-dependent effects
on collagen synthesis in vitro have been reported in serumactivated rat cardiac fibroblasts [28–32] suggesting that adenosine may play an anti-fibrotic role in the heart. In contrast,
non-activated cardiac human fibroblasts treated with NECA
demonstrated an increase in collagen secretion [33].
Furthermore, rat fibroblasts overexpressing A2B adenosine
increased collagen synthesis in response to NECA [30]. In
the current study, we also observed a tendency of nonactivated Sca1+CD31− cells to increase intracellular procollagen I levels and collagen I secretion in response to
NECA. These effects were A2B receptor-specific because
NECA had no effect on A2BKO cells. Thus, A2B receptordependent regulation of collagen I production by cardiac
Purinergic Signalling (2014) 10:477–486
483
Fig. 5 Comparative analysis of
MI-induced changes in cardiac
Sca1+CD31− stromal cell
populations of WT and A2BKO
ventricles. Representative
cytofluorographic dot plots (a) of
CD31 and Sca1 cell-surface
staining of CD45− myocyte-free
cell populations obtained from
ventricles of WT and A2BKO
hearts before (d0) and on days 7
(d7) and 14 (d14) after MI. The
percentages (b) and the numbers
of Sca1+CD31− per milligram of
tissue (c) are presented as
means±SEM of five animals
in each group. Asterisks indicate
statistical differences
(*p<0.05, **p<0.01) between
corresponding WT and A2BKO
values analyzed by one-way
ANOVA with Bonferroni
post-hoc tests
Sca1+CD31− stromal cells by adenosine in vitro is similar to
that previously found in cardiac fibroblasts, which is highly
dependent on culture conditions and particularly on their
activation status. Importantly, treatment of Sca1+CD31− stromal cells with NECA had no effect on the expression of
αSMA in these cells regardless of their activation status.
In vivo, analysis of MI-induced αSMA expression in cardiac stromal cell population revealed a complex, dynamic, and
time-dependent process. A rapid accumulation of αSMAexpressing cells was seen, reaching a maximum by post-MI
day 5. The rapid accumulation of αSMA-expressing
myofibroblasts in the injured area is believed to be important
for scar contraction and proper wound healing [26].
Abrogation of A2B receptor signaling in A2BKO mice had
no effect on the increase of αSMA-expressing cells. Thus, our
in vivo results are in agreement with data obtained in cell
culture experiments suggesting that A2B receptors play no role
in generation of αSMA-expressing cells.
The deactivation of myofibroblasts is also believed to be
critical for proper scar formation [26]. This process may
involve apoptotic clearance [34] or de-differentiation of
myofibroblasts accompanied by the loss of αSMA expression
[35–37]. Indeed, after reaching their peak, the numbers of
αSMA-expressing cells progressively declined over the next
16 days to nearly pre-infarct levels. It is during this phase
when the difference between A2BKO and WT hearts becomes
evident; the numbers of αSMA-expressing cells remained
significantly higher in WT compared with A2BKO hearts. At
the same time, we found no significant difference in proportion of non-viable αSMA-expressing cells between WT and
A2BKO hearts. Taken together, our data suggest that A2B
receptor signaling promotes retention of αSMA-expressing
cells more likely by delaying myofibroblast de-differentiation
rather than due to a decrease in their death rate. Although the
precise mechanism of A2B receptor-dependent regulation of
the deactivation of αSMA-expressing cells remains to be
addressed in future cell-fate tracking experiments, our current
study revealed a new level of complexity of adenosine actions
in the heart. It also demonstrated that the effects of A2B
receptors in the regulation of scar formation are timedependent, and its role in this process may become more
important at the healing phase of myocardial infarction.
The ramifications of altering the temporal regulation of
αSMA-expressing cells on myocardial scar properties require
further investigation. In support of beneficial effects of A2B
receptor signaling in myocardial repair, it has been reported
484
Purinergic Signalling (2014) 10:477–486
Fig 6 Comparative analysis of
MI-induced changes in αSMA
and collagen I expression in
cardiac Sca1+CD31− stromal cell
populations of WT and A2BKO
ventricles. Representative
cytofluorographic dot plots (a) of
intracellular αSMA and collagen
I (Col1) expression in cardiac
Sca1+CD31− stromal cell
populations obtained from
ventricles of WT and A2BKO
hearts before (d0) and on days 7
(d7) and 14 (d14) after MI. The
numbers of αSMA+Col1+ (b),
αSMA+Col1− (c), αSMA−Col1−
(d), and Col1+αSMA− (e) cells
per milligram of tissue are
presented as means±SEM of 4
animals in each group. Asterisks
indicate statistical differences
(*p<0.05, **p<0.01) between
corresponding WT and A2BKO
values analyzed by one-way
ANOVA with Bonferroni posthoc tests
that long-term stimulation of A2B receptors started one week
after MI infarction significantly ameliorated adverse remodeling in the injured heart [38]. In contrast, activation of A2B
receptor signaling at earlier stages of MI has been suggested to
contribute to adverse remodeling by promoting an inflammatory response [39]. The retention of αSMA-expressing cells
may help keep the injured tissue strong and contracted, thus
preserving it from potential rupture. On the other hand, abnormal persistence of αSMA-expressing myofibroblasts may
lead to interstitial fibrosis resulting in exaggerated mechanical
stiffness, disorganized contraction, and worsening myocardial
ischemia. In support of the latter concept, it has been reported
that only WT but not A2BKO mice developed reactive interstitial fibrosis in response to MI [40]. Furthermore, inhibition
of A2B receptors with the selective antagonist GS-6201
reduced interstitial fibrosis in response to MI [41].
Although seemingly contradictory, these studies demonstrated a multifaceted and time-dependent regulation of
MI-induced remodeling by A2B receptors. Due to wellknown limitations of studies involving global knockout
or systemic pharmacological modulation of A2B receptor
signaling in such a complex process as MI, it is difficult
to differentiate the direct effects of adenosine on stromal
cells from indirect effects of other cells, e.g., invading
leukocytes also known to be regulated by adenosine via A2B
adenosine receptors [42, 43].
Despite these limitations, our study demonstrated for the
first time that resident cardiac Sca1+CD31− cells represent a
substantial population of MI-induced αSMA-expressing cells
and therefore can actively participate in scar formation.
Furthermore, a proportion of Sca1+CD31− in total nonhematopoietic cell population and their numbers increased
nearly two-fold one week after MI and remained significantly
higher in WT compared with A2BKO hearts. Analysis of
αSMA and collagen I expression suggested that almost all
MI-induced changes in total Sca1+CD31− cell population can
be attributed to generation of αSMA-expressing Sca1+CD31−
cells comprised of both collagen-positive and collagennegative populations. Like in general CD31− stromal
cell population, the numbers of these cells remained
significantly higher in WT compared with A2BKO hearts
indicating that their deactivation is regulated by the A2B
receptor signaling. Thus, we conclude that A2B receptors
play an important role the in regulation of dynamic changes
in populations of α-SMA-expressing Sca1+CD31− stromal
cells induced by MI.
In summary, our study revealed a significant contribution
of cardiac Sca1+CD31− cells to the accumulation of αSMAexpressing cells after MI and implicated A2B receptor signaling in regulation of myocardial repair and remodeling by
delaying deactivation of these cells. It is plausible that this
phenomenon may also contribute in part to the beneficial
Purinergic Signalling (2014) 10:477–486
effects of mesenchymal stem-like cells seen after their transplantation to the injured heart.
Acknowledgements This work was supported by the National Institutes of Health National Heart, Lung and Blood Institute [grant
R01HL095787 and K08HL094703], National Cancer Institute [grant
R01CA138923], American Heart Association Research Grant-in-Aid
[13GRNT16580020], and Vanderbilt Clinical and Translational Science
Award (CSTA) [grant UL1 RR024975-01] from the National Institutes of
Health National Center for Research Resources (Vanderbilt Institute for
Clinical and Translational Research CTSA grant VR5622).
References
1. Rossini A, Frati C, Lagrasta C, Graiani G, Scopece A, Cavalli S,
Musso E, Baccarin M, Di SM, Fagnoni F, Germani A, Quaini E,
Mayr M, Xu Q, Barbuti A, DiFrancesco D, Pompilio G, Quaini F,
Gaetano C, Capogrossi MC (2011) Human cardiac and bone marrow
stromal cells exhibit distinctive properties related to their origin.
Cardiovasc Res 89:650–660
2. Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita
N, Blusztajn A, Terrovitis J, Kusuoka H, Marban L, Marban E (2012)
Direct comparison of different stem cell types and subpopulations
reveals superior paracrine potency and myocardial repair efficacy
with cardiosphere-derived cells. J Am Coll Cardiol 59:942–953
3. Huang C, Gu H, Yu Q, Manukyan MC, Poynter JA, Wang M (2011)
Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion. PLoS
One 6:e29246
4. Matsuura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H, Sano
M, Toko H, Akazawa H, Sato T, Nakaya H, Kasanuki H, Komuro I
(2004) Adult cardiac Sca-1-positive cells differentiate into beating
cardiomyocytes. J Biol Chem 279:11384–11391
5. Pfister O, Mouquet F, Jain M, Summer R, Helmes M, Fine A,
Colucci WS, Liao R (2005) CD31− but Not CD31+ cardiac side
population cells exhibit functional cardiomyogenic differentiation.
Circ Res 97:52–61
6. Wang X, Hu Q, Nakamura Y, Lee J, Zhang G, From AH, Zhang J
(2006) The role of the sca-1+/CD31− cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 24:
1779–1788
7. Mohri T, Fujio Y, Obana M, Iwakura T, Matsuda K, Maeda M,
Azuma J (2009) Signals through glycoprotein 130 regulate the endothelial differentiation of cardiac stem cells. Arterioscler Thromb
Vasc Biol 29:754–760
8. Liang SX, Tan TY, Gaudry L, Chong B (2010) Differentiation and
migration of Sca1+/CD31− cardiac side population cells in a murine
myocardial ischemic model. Int J Cardiol 138:40–49
9. Matsuura K, Honda A, Nagai T, Fukushima N, Iwanaga K, Tokunaga
M, Shimizu T, Okano T, Kasanuki H, Hagiwara N, Komuro I (2009)
Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 119:2204–2217
10. Ryzhov S, Goldstein AE, Novitskiy SV, Blackburn MR, Biaggioni I,
Feoktistov I (2012) Role of A2B adenosine receptors in regulation of
paracrine functions of stem cell antigen 1-positive cardiac stromal
cells. J Pharmacol Exp Ther 341:764–774
11. Ryzhov S, Zhang Q, Biaggioni I, Feoktistov I (2013) Adenosine A2B
receptors on cardiac stem cell antigen (Sca)-1-positive stromal cells
play a protective role in myocardial infarction. Am J Pathol 183:665–
672
12. Tateishi K, Ashihara E, Takehara N, Nomura T, Honsho S, Nakagami
T, Morikawa S, Takahashi T, Ueyama T, Matsubara H, Oh H (2007)
485
Clonally amplified cardiac stem cells are regulated by Sca-1 signaling
for efficient cardiovascular regeneration. J Cell Sci 120:1791–1800
13. Takamiya M, Haider KH, Ashraf M (2011) Identification and
characterization of a novel multipotent sub-population of Sca1+ cardiac progenitor cells for myocardial regeneration. PLoS
One 6:e25265
14. Martin BJ, McClanahan TB, Van Wylen DG, Gallagher KP (1997)
Effects of ischemia, preconditioning, and adenosine deaminase inhibition on interstitial adenosine levels and infarct size. Basic Res
Cardiol 92:240–251
15. Willems L, Reichelt ME, Molina JG, Sun CX, Chunn JL, Ashton KJ,
Schnermann J, Blackburn MR, Headrick JP (2006) Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts. Cardiovasc Res 71:79–87
16. Fredholm BB (2007) Adenosine, an endogenous distress signal,
modulates tissue damage and repair. Cell Death Differ 14:1315–1323
17. Gharibi B, Abraham AA, Ham J, Evans BA (2012) Contrasting
effects of A1 and A2b adenosine receptors on adipogenesis. Int J
Obes (Lond) 36:397–406
18. Gharibi B, Abraham AA, Ham J, Evans BA (2011) Adenosine
receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes. J Bone
Miner Res 26:2112–2124
19. Ham J, Evans BA (2012) An emerging role for adenosine and
its receptors in bone homeostasis. Front Endocrinol (Lausanne) 3:
113
20. Carroll SH, Wigner NA, Kulkarni N, Johnston-Cox H, Gerstenfeld
LC, Ravid K (2012) A2B adenosine receptor promotes mesenchymal
stem cell differentiation to osteoblasts and bone formation in vivo. J
Biol Chem 287:15718–15727
21. Ciciarello M, Zini R, Rossi L, Salvestrini V, Ferrari D, Manfredini R,
Lemoli RM (2013) Extracellular purines promote the differentiation
of human bone marrow-derived mesenchymal stem cells to the
osteogenic and adipogenic lineages. Stem Cells Dev 22:1097–1111
22. He W, Mazumder A, Wilder T, Cronstein BN (2013) Adenosine
regulates bone metabolism via A1, A2A, and A2B receptors in bone
marrow cells from normal humans and patients with multiple myeloma. FASEB J 27:3446–3454
23. Carlson S, Trial J, Soeller C, Entman ML (2011) Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction. Cardiovasc Res 91:99–107
24. Cieslik KA, Trial J, Entman ML (2011) Defective myofibroblast
formation from mesenchymal stem cells in the aging murine heart
rescue by activation of the AMPK pathway. Am J Pathol 179:1792–
1806
25. Cieslik KA, Trial J, Carlson S, Taffet GE, Entman ML (2013)
Aberrant differentiation of fibroblast progenitors contributes to fibrosis in the aged murine heart: role of elevated circulating insulin levels.
FASEB J 27:1761–1771
26. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L,
Narula J (2010) Myocardial remodeling after infarction: the role of
myofibroblasts. Nat Rev Cardiol 7:30–37
27. Stefanovic B, Schnabl B, Brenner DA (2002) Inhibition of collagen
alpha 1(I) expression by the 5’ stem-loop as a molecular decoy. J Biol
Chem 277:18229–18237
28. Dubey RK, Gillespie DG, Mi Z, Jackson EK (1997)
Exogenous and endogenous adenosine inhibits fetal calf
serum-induced growth of rat cardiac fibroblasts: role of A2B
receptors. Circulation 96:2656–2666
29. Dubey RK, Gillespie DG, Jackson EK (1998) Adenosine inhibits
collagen and protein synthesis in cardiac fibroblasts: role of A2B
receptors. Hypertension 31:943–948
30. Chen Y, Epperson S, Makhsudova L, Ito B, Suarez J, Dillmann W,
Villarreal F (2004) Functional effects of enhancing or silencing
adenosine A2b receptors in cardiac fibroblasts. Am J Physiol 287:
H2478–H2486
486
31. Epperson SA, Brunton LL, Ramirez-Sanchez I, Villarreal F (2009)
Adenosine receptors and second messenger signaling pathways in rat
cardiac fibroblasts. Am J Physiol Cell Physiol 296:C1171–C1177
32. Villarreal F, Epperson SA, Ramirez-Sanchez I, Yamazaki KG,
Brunton LL (2009) Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for Epac and PI3K. Am J Physiol 296:C1178–
C1184
33. Zhong H, Belardinelli L, Zeng D (2011) Pro-fibrotic role of the A2B
adenosine receptor in human cardiac fibroblasts. J Card Fail 17:S65
34. Desmouliere A, Redard M, Darby I, Gabbiani G (1995) Apoptosis
mediates the decrease in cellularity during the transition between
granulation tissue and scar. Am J Pathol 146:56–66
35. Hecker L, Jagirdar R, Jin T, Thannickal VJ (2011) Reversible differentiation of myofibroblasts by MyoD. Exp Cell Res 317:1914–1921
36. Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, Benner C,
Iwaisako K, Moore-Morris T, Scott B, Tsukamoto H, Evans SM,
Dillmann W, Glass CK, Brenner DA (2012) Myofibroblasts revert to
an inactive phenotype during regression of liver fibrosis. Proc Natl
Acad Sci U S A 109:9448–9453
37. Garrison G, Huang SK, Okunishi K, Scott JP, Kumar Penke LR,
Scruggs AM, Peters-Golden M (2013) Reversal of myofibroblast
differentiation by prostaglandin E2. Am J Respir Cell Mol Biol 48:
550–558
38. Wakeno M, Minamino T, Seguchi O, Okazaki H, Tsukamoto O,
Okada K, Hirata A, Fujita M, Asanuma H, Kim J, Komamura K,
Purinergic Signalling (2014) 10:477–486
39.
40.
41.
42.
43.
Takashima S, Mochizuki N, Kitakaze M (2006) Long-term stimulation of adenosine A2b receptors begun after myocardial infarction
prevents cardiac remodeling in rats. Circulation 114:1923–1932
Toldo S, Zhong H, Mezzaroma E, Van TB, Kannan H, Zeng D,
Belardinelli L, Voelkel N, Abbate A (2012) GS-6201, a selective
blocker of the A2B adenosine receptor, attenuates cardiac remodeling
following acute myocardial infarction in the mouse. J Pharmacol Exp
Ther 343:587–595
Maas JE, Koupenova M, Ravid K, Auchampach JA (2008) The A2B
adenosine receptor contributes to post-infarction heart failure.
Circulation 118:S946
Zhang H, Zhong H, Everett TH, Wilson E, Chang R, Zeng D,
Belardinelli L, Olgin JE (2014) Blockade of A2B adenosine receptor
reduces left ventricular dysfunction and ventricular arrhythmias
1 week after myocardial infarction in the rat model. Heart Rhythm
11:101–109
Novitskiy SV, Ryzhov S, Zaynagetdinov R, Goldstein AE,
Huang Y, Tikhomirov OY, Blackburn MR, Biaggioni I,
Carbone DP, Feoktistov I, Dikov MM (2008) Adenosine receptors
in regulation of dendritic cell differentiation and function. Blood 112:
1822–1831
Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Blackburn
MR, Biaggioni I, Feoktistov I (2008) Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines. J Pharmacol Exp Ther 324:694–700